Brain scans reveal hidden vascular clues in early Alzheimer's
NCT ID NCT06322121
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study uses MRI scans to track how blood vessels in the brain change over time in people with early Alzheimer's disease and healthy volunteers. Researchers aim to understand if reduced blood vessel reactivity is an early sign of dementia. The study involves 120 participants and does not test any drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify early markers for dementia and guide future treatments targeting blood vessel health.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results may not apply to all dementia patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Leids Universitair Medisch Centrum
Leiden, 2333 ZA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?